Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 34 | 2023 | 1721 | 7.160 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2023 | 3362 | 3.450 |
Why?
|
| Prostate | 15 | 2023 | 378 | 3.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 17 | 2023 | 294 | 2.850 |
Why?
|
| Prostatic Hyperplasia | 2 | 2020 | 88 | 1.310 |
Why?
|
| Prostatectomy | 8 | 2023 | 471 | 1.150 |
Why?
|
| Contrast Media | 9 | 2023 | 1078 | 1.010 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2022 | 1204 | 0.990 |
Why?
|
| Male | 35 | 2023 | 40988 | 0.860 |
Why?
|
| Mobile Applications | 1 | 2023 | 63 | 0.830 |
Why?
|
| Radiology | 1 | 2023 | 194 | 0.760 |
Why?
|
| Neoplasm Grading | 6 | 2023 | 357 | 0.710 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 298 | 0.620 |
Why?
|
| Retrospective Studies | 11 | 2023 | 8496 | 0.560 |
Why?
|
| Humans | 35 | 2023 | 86678 | 0.550 |
Why?
|
| Laser Therapy | 3 | 2020 | 142 | 0.460 |
Why?
|
| Middle Aged | 16 | 2022 | 25040 | 0.440 |
Why?
|
| Prospective Studies | 6 | 2021 | 4214 | 0.440 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 1566 | 0.400 |
Why?
|
| Aged | 10 | 2022 | 18423 | 0.350 |
Why?
|
| Feasibility Studies | 4 | 2019 | 751 | 0.340 |
Why?
|
| Image Enhancement | 4 | 2021 | 563 | 0.320 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 1992 | 0.280 |
Why?
|
| Reproducibility of Results | 7 | 2022 | 2706 | 0.280 |
Why?
|
| Adult | 6 | 2019 | 25659 | 0.220 |
Why?
|
| Water | 2 | 2023 | 277 | 0.220 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2021 | 96 | 0.220 |
Why?
|
| Time | 1 | 2022 | 77 | 0.210 |
Why?
|
| Meglumine | 2 | 2021 | 39 | 0.210 |
Why?
|
| Pathologists | 1 | 2021 | 24 | 0.200 |
Why?
|
| Organometallic Compounds | 2 | 2021 | 132 | 0.190 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 144 | 0.190 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 73 | 0.180 |
Why?
|
| ROC Curve | 2 | 2018 | 752 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2018 | 36 | 0.160 |
Why?
|
| Gadolinium | 1 | 2018 | 103 | 0.160 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 99 | 0.150 |
Why?
|
| Multimodal Imaging | 1 | 2018 | 110 | 0.150 |
Why?
|
| Biopsy | 1 | 2019 | 1163 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 579 | 0.120 |
Why?
|
| Epithelium | 1 | 2015 | 319 | 0.120 |
Why?
|
| Artifacts | 1 | 2015 | 244 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1673 | 0.110 |
Why?
|
| Porosity | 1 | 2011 | 60 | 0.100 |
Why?
|
| Materials Testing | 1 | 2011 | 91 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 2264 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2011 | 178 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 663 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 318 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2011 | 1286 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2021 | 1078 | 0.050 |
Why?
|
| Motion | 1 | 2022 | 85 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 46 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 361 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2021 | 840 | 0.040 |
Why?
|
| Image-Guided Biopsy | 1 | 2018 | 66 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2018 | 289 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 162 | 0.040 |
Why?
|
| Anisotropy | 1 | 2015 | 62 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 93 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 989 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 2216 | 0.030 |
Why?
|
| Particle Size | 1 | 2011 | 122 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7998 | 0.020 |
Why?
|